Validation of the 7th TNM classification for non-small cell lung cancer: A retrospective analysis on prognostic implications for operated node-negative cases

References

• Globocan 2008. Available from: http://www.globocan.iarc.fr [cited 25 June 2012].
   Google Scholar
• The national lung cancer registry in Sweden. Available from: http://www.roc.se/lungca.asp [cited 25 June 2012].
   Google Scholar
• Groome PA, Bolejack V, Crowley JJ, Kennedy C, Krasnik M, Sobin LH, et al. The IASLC Lung Cancer Staging Project: Validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:694–705.
   PubMed Web of Science ®Google Scholar
• Mountain CF. Revisions in the international system for staging lung cancer. CHEST 1997;111:1710–7.
   PubMed Web of Science ®Google Scholar
• Rami-Porta R, Ball D, Crowley J, Giroux DJ, Jett J, Travis WD, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2:593–602.
   PubMed Web of Science ®Google Scholar
• Goldstraw P, Crowley JJ, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:706–142.
   PubMed Web of Science ®Google Scholar
• Arriagada R, Auperin A, Burdett S, Higgins JP, Johnson DH, Le Chevalier, et al. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: Two meta-analyses of individual patient data. NSCLC Meta-analyses Collaborative Group. Lancet 2010;375:1267–77.
   PubMed Web of Science ®Google Scholar
• Rekhtman N. Neuroendocrine tumors of the lung: An update. Arch Pathol Lab Med 2010;134:1628–38.
   PubMed Web of Science ®Google Scholar
• Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009;361:32–9.
   PubMed Web of Science ®Google Scholar
• Shiono S, Abiko M, Sato T. Positron emission tomography/computed tomography and lymphovascular invasion predicts recurrence in stage I lung cancers. J Thorac Oncol 2011;6:43–7.
   PubMed Web of Science ®Google Scholar
• Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008;26:3552–9.
   PubMed Web of Science ®Google Scholar
• Manac´h D, Riquet M, Medioni J, Le Pimpéc-Barthes F, Dujon A, Danel C. Visceral pleura invasion by non-small cell lung cancer: An underrated bad prognostic factor. Ann Thorac Surg 2001;71:1088–93.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Yoshida J, Nagai K, Nishimura M, Ishii G, Morishita Y, et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;130:160–5.
   PubMed Web of Science ®Google Scholar
• Li Z, Yu Y, Lu J, Luo Q, Wu C, Liao M, et al. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China. J Thorac Oncol 2009; 4:702–9.
   PubMed Web of Science ®Google Scholar
• Lardinois D, De Leyn P, Van Schil P, Rami Porta R, Waller D, Passlick B, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006;30:787–92.
   PubMed Web of Science ®Google Scholar
• Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg 2011;141:662–70.
   PubMed Web of Science ®Google Scholar
• Kameyama K, Takahashi M, Ohata K, Igai H, Yamashina A, Matsuoka T, et al. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single Institution. J Thorac Cardiovasc Surg 2009;137:1180–4.
   PubMed Web of Science ®Google Scholar
• Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, et al. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 2009;138:412–8.
   PubMed Web of Science ®Google Scholar
• Yano T. Morodomi Y, Ito K, Yoshida T, Haro A, Shoji F, et al. Verification of the newly proposed T category (seventh edition of the tumor, node, and metastasis classification from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size. J Thorac Oncol 2010;5:45–8.
   PubMed Web of Science ®Google Scholar
• Strand TE, Rostad H, Wentzel-Larsen T, von Plassen C. A population-based evaluation of the seventh edition of the TNM system for lung cancer. Eur Respir J 2010;36:401–7.
   PubMed Web of Science ®Google Scholar
• Ruffini E, Filosso PL, Bruna MC, Coni F, Cristofori RC, Mossetti C, et al. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer – Lung Cancer Staging Project: A validation study from a single-centre experience. Eur J Cardiothorac Surg 2009;36:1037–44.
   PubMed Web of Science ®Google Scholar
• Veeramachaneni NK, Battafarano RJ, Meyers BF, Bell Zoole J, Patterson GA. Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: A negative impact on survival. Eur J Cardiothorac Surg 2007;33:466–9.
   Web of Science ®Google Scholar
• Patz EF, Rossi S, Harpole DH, Herndon JE, Goodman PC. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest 2000;117:1568–71.
   PubMed Web of Science ®Google Scholar
• Takeda S, Fukai S, Komatsu H, Memoto E, Nakamura K, Murakami M. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer. Ann Thorac Surg 2005;79:1142–6.
   PubMed Web of Science ®Google Scholar
• Ou SH, Zell JA, Ziogas A, Anton-Culver H. Prognostic significance of the non-sized-based AJCC T2 descriptors: Visceral pleura invasion, hilar atelectasis or obstructive pneumonitis in stage IB, non-small cell lung cancer is dependent on tumor size. Chest 2008;133:662–9.
   PubMed Web of Science ®Google Scholar
• Koike T, Yamato Y, Asamura H, Tsuchiya R, Sohara Y, Egushi K, et al. Improvements in surgical results for lung cancer from 1989 to 1999 in Japan. J Thorac Oncol 2009;4:1364–9.
   PubMed Web of Science ®Google Scholar
• Ruffini E, Asioli S, Filosso PL, Buffoni L, Bruna MC, Mossetti C, et al. Significance of the presence of microscopic vascular invasion after complete resection of stage I–II pT1. T2N0 non-small cell lung cancer and its relation with T-size categories. J Thorac Oncol 2011;6:319–26.
   PubMed Web of Science ®Google Scholar